UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026373
Receipt number R000030309
Scientific Title A Study on the dermatological efficacy of physical therapy for healthy skin (4)
Date of disclosure of the study information 2017/03/03
Last modified on 2017/05/12 17:01:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the dermatological efficacy of physical therapy for healthy skin (4)

Acronym

Evaluation of physical therapy for skin

Scientific Title

A Study on the dermatological efficacy of physical therapy for healthy skin (4)

Scientific Title:Acronym

Evaluation of physical therapy for skin

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the anti-inflammatory effect of physical therapy for healthy male skin

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

-Change of transepidermal water loss after 2 weeks of physical therapy treatment
-Change of skin hydration after 2 weeks of physical therapy treatment
-Change of skin color after 2 weeks of physical therapy treatment
-Evaluation of anti-inflammatory effect after 2 weeks of physical therapy.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Apply the physical therapy on the skin of upper arm for 2 hours 4 times every week for 2 weeks.

Interventions/Control_2

Apply the placebo therapy on the skin of upper arm for 2 hours 4 times every week for 2 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male

Key inclusion criteria

Healthy male

Key exclusion criteria

-Subjects with photosensitive dermatitis.
-Subjects with clinically-significant disorder at the test site
-Subjects who go to hospital regularly or routinely taking oral medicine for disease: gastrointestinal system, liver, kidney, heart, and blood pressure.
-Subjects who are routinely taking oral medicine for sunburn, chloasma, and freckles.
-Subjects who are deemed inappropriate to participate in this study by the principle investigator.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takatoshi Murase

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan

TEL

0285-68-7871

Email

murase.takatoshi@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tetsuya Kuwano

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan

TEL

0285-68-7459

Homepage URL


Email

kuwano.tetsuya@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 22 Day

Date of IRB


Anticipated trial start date

2017 Year 03 Month 03 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 03 Month 02 Day

Last modified on

2017 Year 05 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030309


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name